Since the onset of the COVID-19 public health emergency, the US Food and Drug Administration (FDA) has hosted a weekly “virtual town hall” meeting to provide the opportunity for stakeholders to ask questions about issues that arise as they develop and implement tests to detect SARS-CoV-2 or diagnose COVID-19. Deborah Komlos at Clarivate explains more about Town Halls Provide Timely Support to SARS-CoV-2 Test Developers.